Opened to its first patient enrollments in 2007, Kids-DOTT is a landmark randomized clinical trial on the duration of anti-clotting medication therapy for venous thromboembolism (VTE) in patients under 21 years old.

Experts in machine learning and artificial intelligence are working with physicians in a range of medical specialties on new tools that aim to continuously improve patient outcomes by harnessing the power of data and analytics.

Cannon was born at 22 weeks and after a long road — 11 months in the hospital and 12 surgeries — he’s home with his family and celebrated his first birthday.

Henry and his family traveled thousands of miles so he could receive specialized care from Dr. George Jallo, who leads the pediatric neurosurgery team, which has world-renowned skill with brain and spinal tumors.

Researchers at Johns Hopkins All Children’s Hospital published a study that investigated the factors that contribute to blood loss during scoliosis surgery.

A project at the hospital is making better-quality pediatric data more available to researchers throughout the Johns Hopkins Health System.

Johns Hopkins All Children’s Hospital was the first certified treatment center in Florida to offer a cutting-edge cellular immunotherapy for advanced leukemia in children and young adults.